Background
==========

Since Macintosh \[[@B1]\] (1943) and Miller \[[@B2]\] (1941) envisioned and developed their direct laryngoscopes attempts have been made to improve on these techniques and equipment using technological advances. Nevertheless, these original techniques have withstood the test of time and remain the mainstay of intubation globally. Direct laryngoscopy (DL) relies on the formation of a "line-of-sight" between the operator and the laryngeal inlet, success reliant on careful head positioning and consistent anatomy. When these conditions are not met, for example in poor tissue mobility, limited mouth opening, or enlarged tongue, the failure rate of intubation with conventional direct laryngoscopy increases \[[@B3]-[@B5]\].

Videolaryngoscopy (VL) is a relatively recent development that attempts to improve the success of tracheal intubation. High-resolution micro cameras and small portable flat-screen monitors are used in an attempt to improve upon the view and success rate of direct laryngoscopy. Similar technologies have been successfully applied to other fields of medicine such as laparoscopic and robotic surgery, making new techniques and procedures possible \[[@B6]\]. The use of Videolaryngoscopy produces a view of the laryngeal inlet independent of the line of sight, particularly when an angulated device is used. This may free them from some of the conditions essential to the success of direct laryngoscopy. There is an assumption that improved lighting and a better view can improve the success of laryngoscopy. This may be incorrect as an improvement in success may be limited by both use of unfamiliar equipment and difficulty placing an endotracheal tube out of the line of sight. Some previous reviews have indicated an advantage when using videolaryngoscopy \[[@B7]-[@B9]\] but a need remains for an systematic evidence based review of the efficacy of videolaryngoscopy above that of direct laryngoscopy.

To appreciate any benefit from the use of videolaryngoscopy we need to appreciate the mechanism and incidence of failure of direct laryngoscopy. The incidence of difficulty encountered during direct laryngoscopy is difficult to ascertain as it depends upon both definition and patient selection. The best evidence available is from a meta-analysis of 50,760 patients in which difficulty at laryngoscopy occurred in 5.8% (95% CI 4.5 -- 7.5) of subjects \[[@B10]\]. Of note, the metanalysis did exclude all patients whose airways were "anatomically abnormal" or in whom DL was thought inappropriate. The definition of difficult laryngoscopy was broad and included all subjects with Cormack and Lehane views 3 or greater. The actual incidence of difficult intubation in this difficult laryngoscopy group is presumably less than 5.8% as many patients with a Cormack and Lehane view 3 can successfully be intubated with direct laryngoscopy and the use of a gum elastic bougie by a reasonably experience practitioner. However, even given this broad definition of difficult laryngoscopy, this still suggests an impressive overall intubation success rate of \>95% \[[@B11]\] for direct laryngoscopy among patients thought to be suitable for this technique. It is this high standard against which the new methods of videolaryngoscopy must be assessed.

Methods
=======

Pubmed and Cochrane review searches were made of all published articles regarding Video Laryngoscopy (VL) from 1999 to April 2011. The following search terms were used: Airtraq, Berci DCI, Bonfils Fibre(er) scope, Bonfils Intubation, Bullard laryngoscope, C-MAC, C-MAC D-blade, CTrach, video laryngoscopy, EVO videolaryngoscope, GlideScope, Glidescope Direct, LMA CTrach, McGrath laryngoscope, McGrath MAC, McGrath series 5, Pentax Airway Scope, Pentax AWS, Rusch, Shikani, Storz Berci, Storz CMAC, Styletscope, V-MAC, Upsherscope, WuScope. X-Lite. Additional search items, for classification purposes, were cervical, cervical limitation, cervical stabilization, obesity, difficult intubation, failed intubation, failed ventilation and education. From this selection all articles were reviewed including randomized controlled trials, observational studies, review articles, meta-analyses and editorials. Bibliographies were checked manually for any relevant articles. Articles published in the ASA meeting proceedings were included and a search made of all ongoing clinical trials in Clinicaltrials.gov.

Inclusion criteria
------------------

Orotracheal intubation.

Procedure performed by trained operators.

English language or accessible translation of key outcomes and methodology.

Device had at least 10 articles published on its use during the previous 5 years (until April 2011).

Exclusion criteria
------------------

Studies of patients aged less than 18 years.

Duplicates, unrelated studies, abstracts, single case reports and small studies (less than 5 subjects).

Manikin studies.

Data extraction
---------------

To summarize the data available from the multiple studies the following measures were extracted from each article:

An overall measure of study quality (based on SIGN recommendations \[[@B12]\]).

Study device.

Summary of method.

Number of subjects in study group.

Number of predicted normal airway (eg MP 1/2).

Number of predicted difficult (eg MP 3/4).

Number of difficult direct laryngoscopies (known or C&L \>3 on Mac DL).

Improvement in laryngeal view compared with direct laryngoscopy.

Average time to intubation. Expressed as central tendency (Mean or median) and variability (95% confidence interval or Inter Quartile Range).

Success rate (percentage) on 1st attempt and overall success (OA).

Results
=======

A total of 980 articles were returned in the initial Pub Med search and 65 additional items were identified using references cited in these articles. After exclusion of articles failing to meet study criteria, 77 articles remained (Figure [1](#F1){ref-type="fig"}, Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).
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Data extraction

           **1st Author**                  **Quality**          **Device**                                                 **Method**                                                 **N device**   **Predicted easy (MP 1-2)**   **Predicted difficult (MP 3-4)**   **Difficult laryngoscopy (C&L 3-4 on DL)**   **Achievement of C&L I view**   **Time to intubation 95% CI or IQR**   **Success% 1st attempt Overall (OA)**
  --------------------------------- -------------------------- ------------ -------------------------------------------------------------------------------------------------------- -------------- ----------------------------- ---------------------------------- -------------------------------------------- ------------------------------- -------------------------------------- ---------------------------------------
      Maharaj (2006) \[[@B13]\]                (+)               Airtraq                                   Randomized, 60 subjects, Airtraq v Mac DL                                       30                    30                               0                                    No data                                  95%                             Mean 12.2                               100% 1st
             Mac DL 70%                (95% CI 9.1 to 15.3)      100% OA                                                                                                                                                                                                                                                                                                                 
      Maharaj (2007) \[[@B14]\]                (+)               Airtraq                  Randomized, 40 subjects, Airtraq v Mac DL, Cervical spine limitation (MILS)                      20                    20                               0                                    No data                                  95%                             Mean 13.2                                No data
             Mac DL 30%               (95% CI 10.6 to 15.7)                                                                                                                                                                                                                                                                                                                              
      Maharaj (2007) \[[@B15]\]                 na               Airtraq                             Observational, Case series, 7 subjects, failed Mac DL                                 7                      0                               7                                    4 C&L 4                                 100%                              Mean 14                                 No data
              Mac DL 0%                (95% CI 8.5 to 18.9)                                                                                                                                                                                                                                                                                                                              
       Ndoko (2007) \[[@B16]\]                 (-)               Airtraq                         Randomized, 70 subjects, Mac DL v Airtraq, risk of difficulty                             35                     0                               35                                   No data                                No data                            Mean 30                                 100% OA
        (95% CI 21.4 to 35.8)                                                                                                                                                                                                                                                                                                                                                            
      Arslan (2009) \[[@B17]\]                 (+)               Airtraq                 Randomized, 86 subjects, Airtraq v CTrach, Cervical spine limitation (collar)                     43                    42                               1                                    No data                                No data                           Mean 25.6                                No data
        (95% CI 21.4 to 29.8)                                                                                                                                                                                                                                                                                                                                                            
     Dhonneur (2009) \[[@B18]\]                (+)               Airtraq                           Randomized, 318 subjects, Airtraq v Mac DL v CTrach, obese                             106                    82                               24                                   No data                                  94%                              Mean 29                                 No data
             Mac DL 51%               (95% CI 26.7 to 31.3)                                                                                                                                                                                                                                                                                                                              
       Lange (2009) \[[@B19]\]                 (+)               Airtraq                           Randomized, 60 subjects, Mac DL then Airtraq v GlideScope                               30                    26                               4                                   4 C&L 3-4                                 90%                             Mean 19.7                                No data
             Mac DL 57%              (95% CI to 15.7 to 23.8)                                                                                                                                                                                                                                                                                                                            
       Malin (2009) \[[@B20]\]                  na               Airtraq                             Observational, Case series, 47 subjects, failed Mac DL                                47                     0                               47                                 47 C&L 2b-4                                85%                              No data                                 95% 1st
              Mac DL 0%                       100%OA                                                                                                                                                                                                                                                                                                                                     
     Turkstra (2009) \[[@B21]\]                (+)               Airtraq              Randomized, cross-over,24 subjects, Airtraq v Mac, cervical spine limitation (MILS)                  24                    24                               0                                       2                                     90%                             Median 8.8                              100% 1st
             Mac DL 20%                 (IQR 6.7 to 10.6)        100% OA                                                                                                                                                                                                                                                                                                                 
    Chalkeidis (2010) \[[@B22]\]               (+)               Airtraq                                   Randomized, 63 subjects, Airtraq v Mac DL                                       35                    25                               10                                   No data                                No data                            Mean 30                                 80% OA
        (95% CI 27.1 to 32.9)                                                                                                                                                                                                                                                                                                                                                            
        Koh (2010) \[[@B23]\]                  (+)               Airtraq                 Randomized, 50 subjects, Airtraq v Mac DL, Cervical spine limitation (collar)                     25                    20                               5                                    No data                                No data                            Mean 50                                 100% OA
      (95% CI to 36.2 to 63.8)                                                                                                                                                                                                                                                                                                                                                           
     Halligan (2003) \[[@B24]\]                 na               Bonfils                                    Observational, Case series, 60 subjects                                        60                    58                               2                                    No data                                No data                           Median 33                                98% OA
           (IQR 24 to 50)                                                                                                                                                                                                                                                                                                                                                                
       Wong (2003) \[[@B25]\]                   na               Bonfils                                    Observational, Case series, 36 subjects                                        36                  No data                         No data                                 No data                                No data                           Median 80                                86% OA
           (No IQR report)                                                                                                                                                                                                                                                                                                                                                               
       Bein (2004) \[[@B26]\]                  (-)               Bonfils                          Randomized, 80 subjects, Bonfils v ILMA, Risk of difficulty                              40                    12                               28                                   No data                                No data                           Median 40                                98% 1st
           (IQR 23 to 77)                    100% OA                                                                                                                                                                                                                                                                                                                                     
       Bein (2004) \[[@B27]\]                   na               Bonfils                             Observational, Case series, 25 subjects, failed Mac DL                                25                     0                            No data                                    25                                  No data                           Median 48                                No data
           (IQR 30 to 80)                                                                                                                                                                                                                                                                                                                                                                
      Wahlen (2004) \[[@B28]\]                 (-)               Bonfils                           Randomized, 48 subjects, Bonfils v Mac DL v Bullard v ILMA                              12                    12                               0                                    No data                                No data                            Mean 52                                 92% OA
        (95% CI 38.1 to 66.1)                                                                                                                                                                                                                                                                                                                                                            
      Byhahn (2008) \[[@B29]\]                 (+)               Bonfils                 Randomized, 76 subjects, Bonfils v Mac DL, Cervical spine limitation (collar)                     38                    38                               0                                  Mac group 17                               82%                              Mean 64                                 71% 1st
              Mac DL 5%               (95% CI 56.1 to 71.9)       82% OA                                                                                                                                                                                                                                                                                                                 
     Corbanese (2009) \[[@B30]\]                na               Bonfils                                    Observational, Case series, 100 subjects                                      100                    100                              0                                    No data                                No data                           Median 30                                89% 1st
           (IQR 25 to 40)                     98% OA                                                                                                                                                                                                                                                                                                                                     
       Corso (2010) \[[@B31]\]                  na               Bonfils                                    Observational, Case series, 10 subjects                                        10                  No data                         No data                                 No data                                No data                            No data                                 No data
     MacQuarrie (1999)\[[@B32]\]                na               Bullard                  Observational, Case series, 80 subjects, Cervical spine limitation (collar)                 40 x 2 grps                28                            No data                                    52                                  No data                           MFIS group                               89% 1st
               Mean 41                        98% OA                                                                                                                                                                                                                                                                                                                                     
        (95% CI 35.3 to 46.7)                                                                                                                                                                                                                                                                                                                                                            
             ISETT group                                                                                                                                                                                                                                                                                                                                                                 
   Mean 45.4 (95% CI 39.4 to 51.4)                                                                                                                                                                                                                                                                                                                                                       
      Shulman (2001) \[[@B33]\]                (-)               Bullard              Randomized, cross-over, 50 subjects, Bullard v FOI, Cervical spine limitation (MILS)            25 x 2 grps              No data                         No data                                 No data                                No data                    Standard Group: Mean 37                         85% OA
        (95% CI 26.2 to 47.8)                                                                                                                                                                                                                                                                                                                                                            
            Cricoid Group                                                                                                                                                                                                                                                                                                                                                                
    Mean 38 (95% CI 26.9 to 49.1)                                                                                                                                                                                                                                                                                                                                                        
      Wahlen (2004) \[[@B28]\]                 (+)               Bullard                            Randomized, 48 subjects, Bullard v Mac v Bonfils v ILMA                                12                    12                               0                                    No data                                  92%                             Mean 16.1                                92% 1st
             Mac DL 33%                (95% CI 12.1 to 20)        92%OA                                                                                                                                                                                                                                                                                                                  
     Nileshwar (2007) \[[@B34]\]               (+)               Bullard             Randomized, 62 subjects, Mac DL then Bullard v ILMA, cervical spine limitation (MILS)                 31                    19                            No data                                    12                                  No data                            Mean 84                                 86% 1st
       (95% CI 66.4 to 101.6)                 90% OA                                                                                                                                                                                                                                                                                                                                     
       Teoh (2010) \[[@B35]\]                  (+)                C-MAC                         Randomized, 400 subjects GlideScope v Pentax AWS v C-MAC v MacDL                          100                    85                               15                                   No data                                  87%                             Mean 31.9                                93% 1st
        (95% CI 28.4 to 35.4)                100% OA                                                                                                                                                                                                                                                                                                                                     
     Dhonneur (2006) \[[@B36]\]                (+)                CTrach                                Randomized, 104 subjects, Mac DL v CTrach, obese                                   52                    43                               9                                    No data                                  75%                              Mean 176                                No data
         (95% CI 166 to 186)                                                                                                                                                                                                                                                                                                                                                             
      Goldman (2006) \[[@B37]\]                 na                CTrach                                    Observational, Case series, 328 subjects                                      328                  No data                         No data                                 No data                                  91%                              No data                                 No data
      Goldman (2006) \[[@B38]\]                 na                CTrach                                     Observational, Case series, 6 subjects                                        6                      3                               3                                       6                                    100%                              No data                                 No data
              Mac DL 0%                                                                                                                                                                                                                                                                                                                                                                  
        Liu (2006) \[[@B39]\]                   na                CTrach                                    Observational, Case series, 100 subjects                                      100                    84                               26                                      9                                     28%                             Median 166                               No data
             Mac DL 59%                  (IQR 114 to 233)                                                                                                                                                                                                                                                                                                                                
     Timmerman (2006) \[[@B40]\]                na                CTrach                                    Observational, Case series, 10 subjects                                        10                  No data                         No data                                 No data                                  30%                              No data                                 No data
     Timmerman (2006) \[[@B41]\]                na                CTrach                                    Observational, Case series, 60 subjects                                        60                  No data                         No data                                    3                                     55%                              No data                                 No data
      Cattano (2007) \[[@B42]\]                 na                CTrach                                 Observational, Case series, 15 subjects, obese                                    15                  No data                         No data                                 No data                                  60%                              No data                                 No data
     Dhonneur (2007) \[[@B43]\]                (+)                CTrach                                    Randomized, 120 subjects, CTrach v MacDL                                       60                  No data                         No data                                 No data                                  93%                              Mean 119                                No data
       (95% CI 107.6 to 130.4)                                                                                                                                                                                                                                                                                                                                                           
        Ng (2007) \[[@B44]\]                   (-)                CTrach                              Randomized trial, 106 subjects, CTrach v GlideScope                                  54                    54                               0                                    No data                                  85%                              Mean 73                                 No data
        (95% CI 63.2 to 82.8)                                                                                                                                                                                                                                                                                                                                                            
        Liu (2008) \[[@B45]\]                  (+)                CTrach                               Randomized, 271 subjects, CTrach v ILMA (Fastrach)                                 134                    118                              16                                      13                                    93%                             Median 116                               93% 1st
             Mac DL 59%                  (IQR 82 to 156)         100% OA                                                                                                                                                                                                                                                                                                                 
      Nickel (2008) \[[@B46]\]                  na                CTrach                                    Observational, Case series, 16 subjects                                        16                  No data                         No data                                 No data                                  44%                              No data                                 No data
      Arslan (2009) \[[@B17]\]                 (+)                CTrach                 Randomized, 86 subjects, Airtraq v CTrach, Cervical spine limitation (collar)                     43                    42                               1                                    No data                                No data                           Mean 66.3                                93% 1st
        (95% CI 57.3 to 75.3)                100% OA                                                                                                                                                                                                                                                                                                                                     
     Dhonneur (2009) \[[@B18]\]                (+)                CTrach                           Randomized, 318 subjects, Airtraq v Mac DL v CTrach, obese                             106                    78                               28                                   No data                                  97%                              Mean 109                                100% OA
             Mac DL 51%,             (95% CI 103.9 to 114.1)                                                                                                                                                                                                                                                                                                                             
        Liu (2009) \[[@B47]\]                   na                CTrach                                    Observational, Case series, 48 subjects                                        48                    18                               30                                      26                                  in 96%                             No data                                 No data
              Mac DL 0%                                                                                                                                                                                                                                                                                                                                                                  
       Malik (2009) \[[@B48]\]                 (+)                CTrach            Randomized, 90 subjects, Pentax AWS v Mac DL v CTrach, cervical spine limitation (MILS)                30                    30                               0                                    No data                                  67%                             Median 46                                84% 1st
             Mac DL 20%                  (IQR 38 to 107)          90% OA                                                                                                                                                                                                                                                                                                                 
        Ng (2009) \[[@B49]\]                    na                CTrach                   Observational, Case series, 50 subjects, cervical spine limitation (MILS)                       50                    45                               5                                       11                                    98%                              No data                                 No data
             Mac DL 44%                                                                                                                                                                                                                                                                                                                                                                  
      Swadia (2009) \[[@B50]\]                  na                CTrach                                    Observational, Case series, 20 subjects                                        20                    20                               0                                    No data                                  60%                             Mean 347.8                               No data
       (95% CI 342.8 to 352.8)                                                                                                                                                                                                                                                                                                                                                           
        Agro (2003) \[[@B4]\]                   na              GlideScope                    Observational, Case series, 15 subjects, C spine limitation (collar)                         15                  No data                         No data                                    10                                    33%                              Mean 38                                 No data
              Mac DL 0%                   (no SD report)                                                                                                                                                                                                                                                                                                                                 
      Cooper (2005) \[[@B51]\]                  na              GlideScope                                  Observational, Case series, 728 subjects                                      728                    579                             148                                    34/133                                  86%                              No data                                 96% OA
             Mac DL 49%                                                                                                                                                                                                                                                                                                                                                                  
       Doyle (2005) \[[@B52]\]                  na              GlideScope                                  Observational, Case series, 747 subjects                                      747                  No data                         No data                                 No data                                No data                            No data                                100 % OA
       Hsiao (2005) \[[@B53]\]                  na              GlideScope                      Observational, Case series, 103 subjects, Mac DL then GlideScope                          103                  No data                         No data                                    22                                    80%                              No data                                 No data
             Mac DL 52%                                                                                                                                                                                                                                                                                                                                                                  
        Lim (2005) \[[@B54]\]                  (+)              GlideScope               Randomized, 60 subjects, GlideScope v Mac DL, Cervical spine limitation (MILS)                    30                    30                               0                               8 in Mac DL group                             67%                             Mean 41.8                                86% 1st
             Mac DL 13%               (95% CI 34.2 to 49.4)       94% OA                                                                                                                                                                                                                                                                                                                 
        Rai (2005) \[[@B55]\]                   na              GlideScope                                  Observational, Case series, 50 subjects                                        50                  No data                         No data                                    1                                     88%                             Median 40                                No data
             Mac DL 44%                   (IQR 30 to 55)                                                                                                                                                                                                                                                                                                                                 
        Sun (2005) \[[@B56]\]                  (+)              GlideScope                           Randomized, 200 subjects, Mac DL then Mac v GlideScope                               100                    88                               12                                      15                                    75%                              Mean 46                                 94% 1st
             Mac DL 59%                 (95% CI 42 to 49)         99% OA                                                                                                                                                                                                                                                                                                                 
     Turkstra (2005) \[[@B57]\]                (+)              GlideScope        Randomized, cross-over, 36 subjects, Mac DL and GlideScope, cervical spine limitation (MILS)             18                    16                               2                                    No data                                No data                            Mean 27                                 No data
        (95% CI 21.0 to 33.0)                                                                                                                                                                                                                                                                                                                                                            
        Ng (2007) \[[@B44]\]                   (-)              GlideScope                               Randomized, 106 subjects, CTrach v GlideScope                                     52                    52                               0                                    No data                                 100 %                             Mean 43                                 No data
        (95% CI 36.9 to 49.1)                                                                                                                                                                                                                                                                                                                                                            
        Xue (2007) \[[@B58]\]                   na              GlideScope                                  Observational, Case series, 91 subjects                                        91                    79                               12                                    19/27                                   74%                              Mean 38                                 97% 1st
             Mac DL 11%               (95% CI 35.7 to 40.3)      100% OA                                                                                                                                                                                                                                                                                                                 
       Malik (2008) \[[@B59]\]                 (+)              GlideScope   Randomized, 120 subjects, GlideScope v Pentax AWS v Mac DL v Truview, Cervical spine limitation (MILS)        30                    30                               0                                    No data                                  70%                             Mean 18.9                                No data
             Mac DL 20%               (95% CI 16.7 to 21.9)                                                                                                                                                                                                                                                                                                                              
     Tremblay (2008) \[[@B60]\]                 na              GlideScope                      Observational, Case series, 400 subjects, Mac DL then GlideScope                          400                    347                              53                                      26                                    90%                              Mean 21                                 84% 1st
             Mac DL 67%               (95% CI 19.6 to 22.4)       99% OA                                                                                                                                                                                                                                                                                                                 
    Robitaille (2008) \[[@B61]\]               (+)              GlideScope                   Randomized, cross over, 20 subjects, cervical spine limitation (MILS)                         20                  No data                         No data                                    1                                     50%                              No data                                 No data
              Mac DL 0%                                                                                                                                                                                                                                                                                                                                                                  
      Bathory (2009) \[[@B62]\]                 na              GlideScope     Observational, Case series, 50 subjects, Mac DL then GlideScope, Cervical spine limitation (MILS)           50                    48                               2                                       50                                    8%                              Median 50                                No data
              Mac DL 0%                   (IQR 41-63 s)                                                                                                                                                                                                                                                                                                                                  
   Stroumpoulis \[[@B63]\] (2009)               na              GlideScope                     Observational, Case series, 112 subjects, Mac DL then GlideScope,                          112                    70                               42                                      41                                    61%                              No data                                 90% 1st
             Mac DL 38%                       98% OA                                                                                                                                                                                                                                                                                                                                     
       Lange (2009) \[[@B19]\]                 (+)              GlideScope                         Randomized, 60 subjects, Mac DL then Airtraq v GlideScope                               30                    27                               3                                       5                                     90%                             Mean 17.3                                97% 1st
             Mac DL 63%               (95% CI 14.8 to 19.8)      100% OA                                                                                                                                                                                                                                                                                                                 
        Liu (2009) \[[@B64]\]                  (+)              GlideScope            Randomized, 70 subjects, GlideScope v Pentax AWS), cervical spine limitation (MILS)                  35                    23                               12                                      20                                    40%                             Mean 71.9                                No data
             Mac DL 20%               (95% CI 55.5 to 88.3)                                                                                                                                                                                                                                                                                                                              
      Maassen (2009) \[[@B65]\]                (+)              GlideScope                 Randomized, 150 subjects, Mac DL then GlideScope v V-MAC v McGrath, Obese                       50                    37                               13                                      17                                  No data                            Mean 33                                 No data
        (95% CI 27.9 to 38.1)                                                                                                                                                                                                                                                                                                                                                            
       Malik (2009) \[[@B66]\]                 (+)              GlideScope                Randomized, 75 subjects,Pentax AWS v GlideScope v Mac DL, Risk of difficulty                     25                     0                               25                                   No data                                  88%                             Median 17                               88 % 1st
           (IQR 12 to 21)                     96% OA                                                                                                                                                                                                                                                                                                                                     
   Nouruzi-Sedeh (2009) \[[@B67]\]             (-)              GlideScope                     Randomized, 200 subjects, Mac DL v GlideScope, untrained operators                         100                  No data                         No data                                 No data                                  66%                              Mean 63                                 93% 1st
             Mac DL 32%               (95% CI 57.0 to 68.9)      100% OA                                                                                                                                                                                                                                                                                                                 
       Teoh (2009) \[[@B68]\]                  (-)              GlideScope                             Randomized, 140 subjects, GlideScope v Pentax AWS                                   70                    62                               8                                    No data                                  81%                            Median 27.8                               No data
           (IQR 22 to 36)                                                                                                                                                                                                                                                                                                                                                                
     Turkstra (2009) \[[@B69]\]                (+)              GlideScope                       Randomized, 80 subjects, GlideScope alone (comparing stylets)                             79                    67                               12                                   No data                                  73%                             Median 37                                92% 1st
               96% OA                                                                                                                                                                                                                                                                                                                                                                    
    Van Zundert (2009)\[[@B70]\]               (+)              GlideScope                     Randomized, 450 subjects, Mac DL then GlideScope v V-MAC v McGrath                         150                    134                              16                                   No data                                No data                            Mean 34                                 No data
        (95% CI 30.8 to 37.2)                                                                                                                                                                                                                                                                                                                                                            
    Hirabayashi (2010) \[[@B71]\]              (-)              GlideScope                               Randomized, 200 subjects, GlideScope v Mac DL                                    100                  No data                         No data                                 No data                                No data                            Mean 64                                 94% 1st
        (95% CI 57.5 to 70.5)                100% OA                                                                                                                                                                                                                                                                                                                                     
      Serocki (2010) \[[@B72]\]                (+)              GlideScope            Randomized, cross-over, 120 subjects GlideScope v V-MAC v Mac DL, Risk of difficulty                120                    68                               52                                      36                                    36%                             Median 33                                91% 1st
              Mac DL 0%                   (IQR 18 to 38)         100% OA                                                                                                                                                                                                                                                                                                                 
        Siu (2010) \[[@B73]\]                   na              GlideScope                                  Observational, Case series, 742 subjects                                      742                    408                             256                                      78                                    62%                              No data                                 No data
       Teoh (2010) \[[@B35]\]                  (+)              GlideScope                     Randomized, 400 subjects, GlideScope v Pentax AWS v CMAC v Mac DL                          100                    71                               29                                   No data                                  78%                              Mean 31                                 91% 1st
        (95% CI 28.0 to 34.0)                100% OA                                                                                                                                                                                                                                                                                                                                     
       Aziz (2011) \[[@B74]\]                   na              GlideScope                                 Observational, Case series, 2004 subjects                                      2004                  1329                             675                                239 failed DL                             No data                            No data                                 No data
      Shippey (2007) \[[@B75]\]                 na               McGrath                                    Observational, Case series, 75 subjects                                        75                    63                               11                                      1                                   No data                           Median 25                                93% 1st
         (IQR 18.5 to 34.4)                   98% OA                                                                                                                                                                                                                                                                                                                                     
      O'Leary (2008) \[[@B76]\]                 na               McGrath                               Observational, Case series, 30 subjects, failed DL                                  30                  No data                         No data                                    12                                    77%                              No data                                 No data
              Mac DL 3%                                                                                                                                                                                                                                                                                                                                                                  
      Maassen (2009) \[[@B65]\]                (+)               McGrath                   Randomized, 150 subjects, Mac DL then GlideScope v V-MAC v McGrath, Obese                       50                    38                               12                                      14                                  No data                            Mean 41                                 8% 1st
        (95% CI 33.9 to 48.1)                100% OA                                                                                                                                                                                                                                                                                                                                     
    Van Zundert (2009)\[[@B70]\]               (+)               McGrath                       Randomized, 450 subjects, Mac DL then GlideScope v V-MAC v McGrath                         150                    133                              17                                   No data                                No data                            Mean 38                                 83% OA
        (95% CI 34.3 to 41.7)                                                                                                                                                                                                                                                                                                                                                            
      Walker (2009) \[[@B77]\]                 (+)               McGrath                                   Randomized, 120 subjects, McGrath v Mac DL                                      60                    58                               2                                    No data                                No data                           Median 47                                95% 1st
           (IQR 39 to 60)                    100% OA                                                                                                                                                                                                                                                                                                                                     
      Hughes (2010) \[[@B78]\]                  na               McGrath                                     Observational, Case series, 6 subjects                                        6                   No data                         No data                                 No data                                No data                            No data                                 No data
      Noppens (2010) \[[@B79]\]                 na               McGrath                         Observational, Case series, 61 subjects, C&L 3-4 failed Mac DL                            61                  No data                         No data                                61 C&L 3-4                                87%                              No data                                 95% OA
              Mac DL 0%                                                                                                                                                                                                                                                                                                                                                                  
       Asai (2008) \[[@B80]\]                   na              Pentax AWS                                  Observational, Case series, 100 subjects                                      100                    100                              0                                    No data                                No data                           Median 35                            96% 1st, 99%OA
           (No IQR report)                                                                                                                                                                                                                                                                                                                                                               
      Enomoto (2008) \[[@B81]\]                (+)              Pentax AWS        Randomized, cross-over, 203 subjects, Mac DL v Pentax AWS, cervical spine limitation (MILS)             203                    194                              9                                       22                                Mac DL 61%                           Mean 54                                     
        (95% CI 52.1 to 55.9)                                                                                                                                                                                                                                                                                                                                                            
    Hirabayashi (2008) \[[@B82]\]               na              Pentax AWS                                  Observational, Case series, 405 subjects                                      405                  No data                         No data                                    16                                  No data                            Mean 42                                 95% 1st
         (95% CI 3.8 to 81)                   100%OA                                                                                                                                                                                                                                                                                                                                     
       Malik (2008) \[[@B59]\]                 (+)              Pentax AWS        Randomized, 120 subjects, Pentax AWS v Mac v GS v Truview, cervical spine limitation (MILS)              30                    30                               0                                    No data                                  97%                             Mean 16.7                                No data
             Mac DL 20%                (95% CI 14 to 19.4)                                                                                                                                                                                                                                                                                                                               
      Suzuki (2008) \[[@B83]\]                  na              Pentax AWS                                  Observational, Case series, 320 subjects                                      320                    265                              55                                      46                                    99%                             Mean 20.1                                96% 1st
             Mac DL 55%                (95% CI 19 to 21.2)       100% OA                                                                                                                                                                                                                                                                                                                 
       Asai (2009) \[[@B84]\]                   na              Pentax AWS                        Observational, Case series, 270 subjects, difficult Mac DLs                             270                    179                              91                                     256                                    96%                              No data                                 No data
              Mac DL 0%                                                                                                                                                                                                                                                                                                                                                                  
    Hirabayashi (2009) \[[@B85]\]              (+)              Pentax AWS                               Randomized, 520 subjects, Mac DL v Pentax AWS                                    264                  No data                         No data                                 No data                                No data                            Mean 44                                 96% 1st
        (95% CI 41.7 to 46.2)                100% OA                                                                                                                                                                                                                                                                                                                                     
        Liu (2009) \[[@B64]\]                  (+)              Pentax AWS             Randomized, 70 subjects, Pentax AWS v GlideScope, Cervical spine limitation (MILS)                  35                    25                               10                                      19                                    97%                             Mean 34.2                                100% OA
             Mac DL 19%               (95% CI 25.6 to 42.8)                                                                                                                                                                                                                                                                                                                              
       Malik (2009) \[[@B48]\]                 (+)              Pentax AWS            Randomized, 90 subjects, Pentax AWS v Mac v CTrach, cervical spine limitation (MILS)                 30                    30                               0                                    No data                                 100%                             Median 10                                93% 1st
             Mac DL 20%                   (IQR 8 to 15)           100%OA                                                                                                                                                                                                                                                                                                                 
       Malik (2009) \[[@B66]\]                 (+)              Pentax AWS                 Randomized, 75 subjects, Pentax AWS v GlideScope v Mac, Risk of difficulty                      25                     1                               24                                   No data                                 100%                             Median 15                               72 % 1st
            (IQR 8 to 31)                    100% OA                                                                                                                                                                                                                                                                                                                                     
       Teoh (2009) \[[@B68]\]                  (+)              Pentax AWS                             Randomized, 140 subjects, Pentax AWS v GlideScope                                   70                    60                               10                                   No data                                  98%                             Median 19                                87% 1st
           (IQR 14 to 4.5)                    100 OA                                                                                                                                                                                                                                                                                                                                     
       Teoh (2010) \[[@B35]\]                  (+)              Pentax AWS                     Randomized, 400 subjects, GlideScope v Pentax AWS v C-MAC v Mac DL                         100                    83                               17                                   No data                                  97%                             Mean 20.6                                95% 1st
        (95% CI 18.3 to 22.9)                100% OA                                                                                                                                                                                                                                                                                                                                     
      Kaplan (2006) \[[@B86]\]                  na                V-MAC                           Observational, Case series, 865 subjects, Mac DL then V-MAC                             865                  No data                         No data                                   123                                    56%                              No data                                 No data
             Mac DL 36%                                                                                                                                                                                                                                                                                                                                                                  
       Cavus (2009) \[[@B87]\]                  na                C-MAC                                     Observational, Case series, 60 subjects                                        60                    42                               18                                   No data                                No data                           Median 16                                87% 1st
            (IQR 6 to 58)                    100% OA                                                                                                                                                                                                                                                                                                                                     
     Jungbauer (2009) \[[@B88]\]               (+)                V-MAC                         Randomized, 200 subjects, Mac DL v V-MAC, at risk of difficulty                           100                     1                               99                                      36                                    45%                              Mean 40                                 No data
             Mac DL 23%               (95% CI 33.9 to 46.1)                                                                                                                                                                                                                                                                                                                              
      Maassen (2009) \[[@B65]\]                (+)                V-MAC                    Randomized, 150 subjects, Mac DL then GlideScope v V-MAC v McGrath, Obese                       50                    37                               13                                      14                                  No data                            Mean 17                                 No data
          (95% CI 15 to 19)                                                                                                                                                                                                                                                                                                                                                              
    Van Zundert (2009)\[[@B70]\]               (+)                V-MAC                        Randomized, 450 subjects, Mac DL then GlideScope v V-MAC v McGrath                         150                    132                              18                                   No data                                No data                            Mean 18                                 No data
        (95% CI 16.1 to 19.9)                                                                                                                                                                                                                                                                                                                                                            
     Meininger (2010) \[[@B89]\]                na                C-MAC                            Observational, Case series, 94 subjects Mac DL then C-MAC                               94                  No data                         No data                                    18                                    43%                              No data                                 No data
             Mac DL 35%                                                                                                                                                                                                                                                                                                                                                                  
      Serocki (2010) \[[@B72]\]                (++)               V-MAC               Randomized, cross-over, 120 subjects GlideScope v V-MAC v Mac DL, Risk of difficulty                120                    68                               52                                      36                                    31%                             Median 27                                No data
              Mac DL 0%                   (IQR 17 to 94)                                                                                                                                                                                                                                                                                                                                 

(Refer to Table [4](#T4){ref-type="table"} for guide to quality assessment grading).

###### 

Level of evidence summary

  **Device**                                 **Outcome**                               **Failed DL**                                                     **Difficult DL (C&L \>/= 3)**                                                                                                                   **At Higher Risk of Difficult DL**                                                                                                                                      **Unselected**
  ------------------------ ------------------------------------------------ ----------------------------------- ---------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------
  **Airtraq**                        **Success 1**st **attempt**                          No data                                                                   No data                                                                                                                         1+, 96-100% \[[@B23]\],\[[@B17]\],\[[@B14]\]                                                                                                                       1+, 93-100% \[[@B19]\],\[[@B13]\]
  **Success Overall**             3, 80-100% \[[@B20]\], \[[@B15]\]          3, 80-100% \[[@B20]\], \[[@B15]\]                   1+, 96-100% \[[@B23]\],\[[@B17]\],\[[@B18]\],\[[@B14]\],\[[@B21]\],\[[@B16]\]                                                                                 1+, 89-100% \[[@B22]\],\[[@B19]\],\[[@B90]\],\[[@B13]\]                                                               
  **% C&L 1 of glottis**          3, 85- 100% \[[@B20]\], \[[@B15]\]         3, 89-100% \[[@B20]\], \[[@B15]\]                              1+, Improvement, 90-95% \[[@B21]\],\[[@B18]\],\[[@B14]\]                                                                                                1+, Improvement, 90-95% \[[@B19]\],\[[@B13]\]                                                                    
  **Time to success**                          No data                                    No data                                              1+, No \[[@B16]\],\[[@B18]\],\[[@B23]\],\[[@B21]\]                                                                                                           1+, No \[[@B13]\],\[[@B22]\]                                                                             
  **Bonfils**                        **Success 1**st **attempt**                     3, 88% \[[@B27]\]                                                         3, 88% \[[@B27]\]                                                                                                                                 1-, 88% \[[@B29]\]                                                                                                                                            3, 89% \[[@B30]\]
  3, 88% \[[@B27]\]                                                                                                                                                                                                                                                                                                                                                                                                  
  **Success Overall**                     3, 96% \[[@B27]\]                          3, 96% \[[@B27]\]                                                         1-, 82% \[[@B29]\]                                                                                                              1-, 86-98% \[[@B30]\],\[[@B25]\],\[[@B28]\],\[[@B24]\]                                                                
  3, 96% \[[@B27]\]                                                                                                                                                                                                                                                                                                                                                                                                  
  **% C&L 1 of glottis**                       No data                                    No data                                                       1-, Improvement, 82% \[[@B29]\])                                                                                                                               No data                                                                                       
  **Time to success**                          No data                                    No data                                                              1-, No \[[@B29]\]                                                                                                                                  1-, No \[[@B28]\]                                                                                  
  **Bullard**                        **Success 1**st **attempt**                          No data                                                              3, 89% \[[@B32]\]                                                                                                                                 1-, 86% \[[@B34]\]                                                                                                                                            1-, 92% \[[@B28]\]
  3, 89% \[[@B32]\]                                                                                                                                                                                                                                                                                                                                                                                                  
  **Success Overall**                          No data                               3, 98% \[[@B32]\]                                          1-, 85-100% OA \[[@B34]\],\[[@B32]\],\[[@B33]\]                                                                                                                 1-, 92% OA \[[@B28]\]                                                                                
  3, 98% \[[@B32]\]                                                                                                                                                                                                                                                                                                                                                                                                  
  **% C&L 1 of glottis**                       No data                                    No data                                                                   No data                                                                                                                                1-, Improvement, 92% \[[@B28]\]                                                                           
  **Time to success**                          No data                                    No data                                                                   No data                                                                                                                                      1-, Yes \[[@B28]\]                                                                                  
  **CTrach**                         **Success 1**st **attempt**                          No data                                                                   No data                                                                                                               1-, 84-93% \[[@B48]\],\[[@B49]\],\[[@B36]\],\[[@B40]\],\[[@B17]\]                                                                           1-, 67-100% \[[@B44]\],\[[@B91]\],\[[@B39]\],\[[@B37]\],\[[@B45]\],\[[@B43]\],\[[@B46]\],\[[@B41]\]
  **Success Overall**                     3, 100% \[[@B38]\]                        3, 95.8% \[[@B47]\]                     1-, 90-100% \[[@B48]\],\[[@B18]\],\[[@B49]\],\[[@B42]\],\[[@B36]\],\[[@B40]\],\[[@B17]\]                                               1-, 93-100% \[[@B44]\],\[[@B91]\],\[[@B39]\],\[[@B37]\],\[[@B45]\],\[[@B43]\],\[[@B46]\],\[[@B41]\],\[[@B50]\]                                    
  **% C&L 1 of glottis**                  3, 100% \[[@B38]\]                        3, 95.8% \[[@B47]\]                          1-, Improvement, 30-98% \[[@B41]\],\[[@B48]\],\[[@B42]\],\[[@B36]\],\[[@B49]\]                                              1-, Improvement, 28-93% \[[@B39]\],\[[@B46]\],\[[@B41]\],\[[@B50]\],\[[@B44]\],\[[@B91]\],\[[@B45]\],\[[@B37]\],\[[@B43]\]                              
  **Time to success**                          No data                                    No data                                                   1-, No \[[@B36]\],\[[@B18]\],\[[@B48]\]                                                                                                                       1-, No \[[@B43]\]                                                                                  
  **GlideScope**                     **Success 1**st **attempt**                          No data                                                              3, 90% \[[@B63]\]                                                                                                     1+ 16-93% \[[@B65]\],\[[@B64]\],\[[@B66]\],\[[@B54]\],\[[@B74]\],\[[@B59]\]                                                      1-, 78-98% \[[@B73]\],\[[@B55]\],\[[@B56]\],\[[@B53]\],\[[@B58]\],\[[@B60]\],\[[@B44]\],\[[@B68]\],\[[@B35]\],\[[@B19]\], \[[@B71]\]
  **Success Overall**                     3, 94% \[[@B74]\]                    3, 98-100% \[[@B62],[@B63]\]      1+, 89-100% \[[@B65]\],\[[@B64]\],\[[@B66]\],\[[@B54]\],\[[@B74]\],\[[@B72]\],\[[@B59]\],\[[@B61]\],\[[@B62]\]   1-, 71-100% \[[@B52]\],\[[@B55]\],\[[@B56]\],\[[@B53]\],\[[@B58]\],\[[@B60]\],\[[@B92]\],\[[@B67]\],\[[@B51]\],\[[@B44]\], \[[@B68]\],\[[@B35]\],\[[@B19]\],\[[@B71]\],\[[@B93]\]  
  **% C&L 1 of glottis**                       No data                         3, Improvement, 8% \[[@B62]\]          1+, Improvement, 33-88% \[[@B4]\],\[[@B72]\],\[[@B64]\],\[[@B61]\],\[[@B54]\],\[[@B59]\],\[[@B66]\]                  1-, Improvement, 62-100% (\[[@B73]\],\[[@B67]\],\[[@B58]\],\[[@B56]\],\[[@B35]\],\[[@B53]\],\[[@B68]\],\[[@B94]\],\[[@B55]\],\[[@B60]\], \[[@B19]\],\[[@B44]\]            
  **Time to success**                          No data                               3, No \[[@B62]\]                                                     1+, No \[[@B59]\],\[[@B72]\]                                                                                                                            1-,No \[[@B71]\]                                                                                   
  **McGrath**                        **Success 1**st **attempt**                          No data                                                                   No data                                                                                                                                            No data                                                                                                                                          1-, 93-95% \[[@B75]\],\[[@B77]\]
  **Success Overall**        3, Improvement, 83-95% \[[@B76]\],\[[@B79]\]                 No data                                                                   No data                                                                                                                               1-, 98-100% \[[@B75]\],\[[@B77]\]                                                                          
  **% C&L 1 of glottis**    3, Improvement, 77\--87% \[[@B76]\],\[[@B79]\]                No data                                                                   No data                                                                                                                                            No data                                                                                       
  **Time to success**                          No data                                    No data                                                                   No data                                                                                                                                       1-, No \[[@B77]\]                                                                                  
  **Pentax AWS**                     **Success 1**st **attempt**                    3, 94% \[[@B84]\])                                                         3, 94% \[[@B84]\]                                                                                                              1+, 72-97% \[[@B59]\],\[[@B48]\],\[[@B95]\]^,^\[[@B64]\]                                                                                           1+, 87-96% \[[@B80]\],\[[@B83]\]^,^\[[@B96]\],\[[@B85]\],\[[@B68]\],\[[@B35]\]
  **Success Overall**                     3, 99% \[[@B84]\]                          3, 99% \[[@B84]\]                                 1+, 97-100% \[[@B59]\],\[[@B48]\],\[[@B95]\],\[[@B64]\],\[[@B81]\]                                                                           1+, 99-100% \[[@B80]\],\[[@B83]\],\[[@B96]\],\[[@B85]\],\[[@B68]\],\[[@B35]\]                                                    
  **% C&L 1 of glottis**            3, Improvement, 96% \[[@B84]\]            3, Improvement, 96% \[[@B84]\]                    1+, Improvement, 97-100% \[[@B59]\],\[[@B64]\],\[[@B48]\],\[[@B81]\],\[[@B66]\]                                                                               1+, Improvement, 97-99% \[[@B68]\],\[[@B35]\],\[[@B83]\]                                                               
  **Time to success**                          No data                                    No data                                                   1+, No \[[@B81]\],\[[@B59]\],\[[@B95]\]                                                                                                                 1+, Yes \[[@B85]\],\[[@B35]\]                                                                            
  **V-MAC**                          **Success 1**st **attempt**                          No data                                                                   No data                                                                                                                                      1+, 64% \[[@B65]\]                                                                                                                                     1-, 87-93% \[[@B87]\],\[[@B68]\]
  **Success Overall**                          No data                                    No data                                           1+, 98-100% \[[@B87]\],\[[@B65]\],\[[@B72]\],\[[@B88]\]                                                                                                 1-, 99-100% \[[@B87]\],\[[@B68]\],\[[@B89]\]                                                                     
  **% C&L 1 of glottis**                       No data                                    No data                                                1+, Improvement, 31-45% \[[@B72]\],\[[@B88]\]                                                                                          1-, Improvement, 43-100% \[[@B89]\],\[[@B86]\],\[[@B35]\],\[[@B87]\]                                                         
  **Time to success**                          No data                                    No data                                                              1+, No \[[@B72]\]                                                                                                                                  1-, No \[[@B35]\]                                                                                  

###### 

Level of evidence for overall success for devices under study

                                                         **Good evidence**   **Weak evidence**   **No evidence**
  ----------------------------------------------------- ------------------- ------------------- -----------------
  **Subjects at higher risk of difficulty during DL**         Airtraq             Bonfils            McGrath
  CTrach                                                      Bullard                           
  GlideScope                                                                                    
  Pentax AWS                                                                                    
  V-MAC                                                                                         
  **Known difficult DL**                                                          Airtraq            McGrath
  Bonfils                                                      V-MAC                            
  Bullard                                                                                       
  CTrach                                                                                        
  GlideScope                                                                                    
  Pentax AWS                                                                                    
  **Failed DL**                                                                   Airtraq            Bullard
  Bonfils                                                      V-MAC                            
  CTrach                                                                                        
  GlideScope                                                                                    
  McGrath                                                                                       
  Pentax AWS                                                                                    

Discussion
==========

The choice of devices to study
------------------------------

When considering the wide variety of airway devices currently available, it is impossible to perform a systematic review of all. With this is mind we limited our review to videolaryngoscopy and applied a rigid, objective inclusion criterion (that of at least 10 publications in the last 5 years) in an attempt to make the selection contemporary. No performance assessment of such a diverse group of devices will ever be perfect, but we have attempted to limit through our objective inclusion criteria those devices that have received the most recent development and where competition exists between different versions of similar equipment. The dynamic nature of the field is illustrated by the decision to discontinue the manufacture of the CTrach by LMA North America in December 2009 during the period of the review. However, the CTrach is still in clinical use and fulfilled the study inclusion criteria so remained in this systematic review. The main technique excluded from this review is flexible fiberoptic bronchoscopy. We feel this method has a specific clinical application and is difficult to compare with standard direct laryngoscopy. The inclusion criteria limited the choice of devices to the GlideScope, V-MAC (including C-MAC and Storz Berci DCI), Bullard, McGrath, Bonfils, Airtraq, Pentax AWS, LMA CTRACH. The recently introduced CMAC and the older Storz DCI and V-MAC were considered versions of the Storz Macintosh video laryngoscope for the purpose of this review and referred to as the V-MAC (video Macintosh) for the remainder of this review.

The devices returned by our methodology are presented in the following diagram (Figure [2](#F2){ref-type="fig"}). We have classified the videolaryngoscopes according their principle shape and form:

1\. Presence of an integrated channel (to guide placement of the endotracheal tube).

2\. The form of a videostylet (with the endotracheal tube placed around the device).

3\. A rigid blade laryngoscopes (without a channel, the endotracheal tube requiring some kind of independent stylet to guide placement).

![**A classification of videolaryngoscopic devices.** CTrach image courtesy of LMA North America. Pentax AWS image courtesy of Ambu USA. Airtraq image courtesy of Prodol Meditec S.A**.** Bonfils and C-MAC Â©2012 Photo Courtesy of KARL STORZ Endoscopy-America, Inc. GlideScope image courtesy of Verathon, USA. The McGrath series 5 image courtesy of Aircraft Medical, UK.](1471-2253-12-32-2){#F2}

Rigid blade laryngoscopes are sub-divided into those with a "standard" blade and those with an angled blade as classified by Niforopoulou and colleagues \[[@B8]\]. There may be differences between the two types with respect to the glottic view on laryngoscopy and ease of intubation. Overall, we feel this classification scheme adds some clarity to the set of devices under examination. Clearly there are design differences between each device within these broad groups (for example presence of antifogging device etc.) Our classification is not novel as previous classifications of videolaryngoscopy have already been published \[[@B9],[@B11]\] but use different criteria to differentiate.

Subject classification
----------------------

### Predicting difficult direct laryngoscopy

This low incidence of difficulty encountered at direct laryngoscopy makes the study of true difficulty problematic. Our standard airway examination is a poor predictor of its occurrence \[[@B11],[@B97]\]. The data from a meta-analysis of 50,760 patients found that the positive predictive value (PPV) of the Mallampati score (at predicting a Cormack and Lehane view 3 or greater) to be 16% \[[@B10]\]. Less than 1 in 5 of those subjects with a "positive" Mallampati score 3 or 4 actually had a Cormack and Lehane view of 3 or greater when DL was performed. Another study has suggested an even lower PPV for the Mallampati score \[[@B98]\]. Consequently any study that solely uses the Mallampati classification to determine difficulty will have a very low incidence of true difficulty encountered at endotracheal intubation. The combination of the limited power of our current airway assessment methods to predict difficult direct laryngoscopy, with the multiple definitions of difficulty makes the subject classification a potential source of controversy. Our criterion for difficult laryngoscopy was a Cormack and Lehane view 3 and above; the definition provided by the ASA in the Practice Guidelines for Management of the Difficult Airway (2003) \[[@B99]\]. We accept that this is a conservative estimate of difficulty, but this criterion actually returned relatively few articles specifically examining this finding at laryngoscopy.

The level of evidence table (Table [2](#T2){ref-type="table"}) was compiled by dividing the articles into four groups:

1\. **Unselected:** this group of articles included subjects considered to have normal airways based on their airway examination and risk factors for difficult laryngoscopy. Even though this group contains a number of subjects that were proven during the study to have true difficult laryngoscopy, the outcomes were reported for the group as a whole and not specifically for this often-small subgroup preventing their specific outcomes to be analyzed.

2\. **At Higher risk of difficult direct laryngoscopy:** these articles included only subjects suspected to have an increased likelihood of difficult intubation because of one or more airway assessment test results or the presence of obesity (BMI \> 35) or cervical spine limitation (collar or MILS). The data were reported for all those subjects fulfilling these criteria, irrespective of whether they were found to be good or poor direct laryngoscopic views during the study. As direct laryngoscopy was not performed before the videolaryngoscopy attempt the subjects had an unknown incidence of true difficult direct laryngoscopy (C&L \>/= 3).

3\. **Difficult direct laryngoscopy** (C&L \>/= 3): These articles included subjects with a documented Cormack and Lehane view III or greater on direct laryngoscopy before the intervention.

4\. **Failed direct laryngoscopy:** These articles included subjects upon whom direct laryngoscopy failed to achieve tracheal intubation.

Quality assessment of the evidence
----------------------------------

Before overall recommendations could be made regarding the efficacy of particular methods of VL, a measure of the quality of each study was made. This is particularly difficult regarding VL as the published studies consist of a mixture of observational (case--control and case series) with few actual randomized, controlled studies. The Agency for Healthcare Research and Quality performed a review of the many methods for assessing the quality of studies and found few that could be applied to both prospective randomized and observational studies \[[@B100]\]. Following their recommendations the current review used the methodology developed by the Scottish Intercollegiate Guidelines Network \[[@B12]\]. This method allowed non-analytical studies (eg. Case reports and case series) to contribute to the overall evidence (although at a much weaker score). Using defined criteria the methodological quality of each analytical study was made to give a quality rating (++ = good, + = adequate, - = poor) (Table [4](#T4){ref-type="table"}). Of note, the SIGN methodology does not allow a quality assessment to be made for non-analytical studies. Each study was reviewed by 2 investigators (DH, OM) and entered into a standard data extraction table (Table [1](#T1){ref-type="table"}). Where disagreement was found, this was discussed and consensus attained. Of note, a single study may appear multiple times in the data extraction table if multiple devices were investigated and data reported for each device. Evidence for one method of VL over another was presented as a level of evidence (Table [4](#T4){ref-type="table"}) and then tied to a grade of recommendation in the discussion of these findings based upon the SIGN criteria \[[@B12]\] (Table [5](#T5){ref-type="table"}).

###### 

Levels of evidence

         
  ----- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1++   RCTs with a very low risk of bias (or high quality meta-analyses, systemic reviews of RCTs)
  1+    RCTs with a low risk of bias (or well conducted meta-analyses, systematic reviews of RCTs)
  1-    RCTs with a high risk of bias (or meta-analyses, systematic reviews or RCTs)
  2++   High quality case--control or cohort studies with a very low risk of confounding/bias/chance and a high probability that the relationship is causal (or High quality systematic reviews of case--control or cohort studies)
  2+    Well conducted case--control or cohort studies with a low risk of confounding/bias/chance and a moderate probability that the relationship is causal
  2-    Case--control or cohort studies with a high risk of confounding/bias/chance and a significant risk that the relationship is not causal
  3     Non-analytic studies, eg. Case reports, case series
  4     Expert opinion

Reproduced from Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ (Clinical research ed 2001;323:334-6) with permission from BMJ Publishing Group Ltd. RCTs, Randomized controlled trials.

###### 

Grades of recommendations

           
  ------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **A**   At least one metanalysis, systematic review, or RCT rated as 1++ and directly applicable to the target population, or A systematic review of RCTs or a body of evidence consisting principally of studies rated as 1+ directly applicable to the target population and demonstrating overall consistency of results
  **B**   A body of evidence including studies rated as 2++ directly applicable to the target population and demonstrating overall consistency of results, or extrapolated evidence from studies rated as 1++ or 1+
  **C**   A body of evidence including studies rated as 2+ directly applicable to the target population and demonstrating overall consistency of results or extrapolated evidence from studies rated as 2++
  **D**   Evidence level 3 or 4, or extrapolated evidence from studies rated as 2+

Reproduced from Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ (Clinical research ed 2001;323:334-6) with permission from BMJ Publishing Group Ltd.

Review of the evidence
----------------------

### The evidence for efficacy of videolaryngoscopy

The performance of a device when compared with direct laryngoscopy relies on three main outcomes: overall success, 1st time success, and time to successful intubation. Glottic view is a desirable outcome but intubation can remain successful and timely despite a limited view of the glottis, and in the case of VL a good laryngeal view does not ensure successful intubation. After careful review of the literature it was decided that little could be summarized or deduced from the Time to Intubation; this outcome being so variably defined between the studies as to make it useless as a form of comparison. We left the summary data from the outcome in the tables for completeness. Instead, we focused on overall success and first time success when compiling our evidence and recommendations, supplemented with information regarding the attainment of glottic view when possible. We followed the methodology developed by the Scottish Intercollegiate Guidelines Network \[[@B12]\] which was recommended by the Agency for Healthcare Research and Quality when assessing the strength of evidence provided by both prospective randomized and observational studies \[[@B100]\].

### Evidence for the use of video laryngoscopy in unselected patients

As previously discussed, the success rate for standard direct laryngoscopy in a general, unselected population without airway pathology is likely to be greater than 95% \[[@B10]\]. It must be noted that there is a difference between an improvement in laryngoscopic success (ie. achieving a view of the glottis) and success of intubation. Direct laryngoscopy is often successful, despite an inadequate view of the glottis. The review of videolaryngoscopy revealed an overall success rate for unselected patients of between 94 to 100% for all of the devices, which is similar to the high success rate of direct laryngoscopy. If used to lower the incidence of difficult intubation, videolaryngoscopy may have little to offer in this unselected patient population due to the low incidence of actual difficulty encountered. However, as we will later discuss, failure can occur during any intubation attempt and the utility of video laryngoscopy must be considered as an alternative intubation device when direct laryngoscopy fails. The performance benefit of videolaryngoscopy as an educational tool was not examined in the current review, but our opinion is that the techniques of videolaryngoscopy should be practiced in a normal population, and competency demonstrated, before attempting to use in a difficult laryngoscopic scenario. There is no current evidence to suggest an increased rate of traumatic airway complications compared with direct laryngoscopy in unselected patients although there are many case reports detailing injuries and hypotheses for their causation \[[@B101]-[@B108]\]. The lack of evidence for a particular device should not be interpreted as evidence against its use, but rather a weakness of the published evidence.

### Evidence for the use of videolaryngoscopy in patients assessed to be at high risk of difficult direct laryngoscopy

When examining overall success the current review demonstrates a high rate of success when using the Airtraq, CTrach, GlideScope, Pentax AWS, and V-MAC videolaryngoscopes supported by level 1+ evidence (good prospective). There is weaker level 3 evidence (case series) to support the use of the Bonfils and Bullard. We found no evidence for the use of the McGrath in this clinical setting. Additionally, the review revealed level 1+ evidence (good prospective) for a higher proportion of Cormack and Lehane grade I views (compared to direct laryngoscopy) when using the Airtraq, CTrach, GlideScope, Pentax AWS, and V-MAC. The review revealed no evidence for the Bonfils, Bullard, and McGrath for the attainment of a higher proportion of C&L grade I views (compared to direct laryngoscopy).

Given the above evidence, for those patients judged to be at risk of having a difficult laryngeal view on direct laryngoscopy we recommend the use of the Airtraq, CTrach, GlideScope, Pentax AWS, and V-MAC, by an operator with reasonable prior experience, to maintain overall success at intubation and increase the likelihood of Cormack and Lehane grade I views compared to direct laryngoscopy (grade A recommendation) based on the SIGN criteria \[[@B12]\] (Table [5](#T5){ref-type="table"}). Such selection does not preclude the possibility of awake intubation in accordance with the ASA Practice Guidelines for Management of the Difficult Airway (2003)\[[@B99]\].

### Evidence for the use of videolaryngoscopy in difficult direct laryngoscopy (C&L \>/= 3)

The current review demonstrates a high level of overall success when using the Airtraq, Bonfils, Bullard, CTrach, Glidescope, and Pentax AWS videolaryngoscopes supported by weak level 3 (case series) evidence. We found no evidence for success for the McGrath or V-MAC in this clinical setting. There is additional weak non-analytic evidence (level 3) to suggest that the use of the CTrach, GlideScope, and Pentax AWS results in an increased percentage of Cormack and Lehane grade I views of the glottis. This is in broad agreement with the previous review by Mihai et al. \[[@B11]\].Given the above evidence, for those patients with known difficulty direct laryngoscopy (C&L view III or IV) we cautiously recommend the use of the Airtraq, Bonfils, Bullard, CTrach, GlideScope, and Pentax AWS (grade D recommendation) by an operator with reasonable prior experience, to maintain the overall success rate of intubation based on the SIGN criteria \[[@B12]\]. This particular recommendation must be considered with respect to the current ASA guidelines that recommend the use of a technique which maintains spontaneous ventilation if at all possible, in patients with known or predicted difficult laryngoscopy.

### Evidence for the use of videolaryngoscopy as a rescue device after failed direct laryngoscopy

After failure of initial direct laryngoscopy morbidity has been shown to increase when more than two attempts are made at laryngoscopy during emergency intubations performed beyond the operating room \[[@B109]\]. Perhaps, given this finding, the Difficult Airway Society of the United Kingdom suggest in their failed intubation guideline, that a provider makes no more than 2 attempts with the same device before moving on to an alternative laryngoscopic device, with the maximum number of laryngoscopic attempts limited to 4 \[[@B110]\]. The ASA guidelines currently do not define the maximum number of attempts with a particular device \[[@B99]\] but suggest that consideration be made to the use of an alternative intubation device if the primary device fails. The videolaryngoscopes would seem to fulfill the requirement of an alternative intubation device if an anesthesia provider is skilled in their use, and the device exhibits a high 1st attempt success rate. The current review demonstrates a high level of overall success, following failed intubation via direct laryngoscopy, when using the Airtraq, Bonfils, CTrach, Glidescope, McGrath, and Pentax AWS videolaryngoscopes supported by weak level 3 evidence (case series). We found no evidence for success for the Bullard or V-MAC in this clinical setting. There is additional weak level 3 evidence (case series) for a high first attempt success rate with use of the Bonfils and Pentax AWS in this setting. There is supplemental weak non-analytic evidence (level 3) to suggest that the use of the Airtraq, CTrach, McGrath, and Pentax AWS results in an increased percentage of Cormack and Lehane grade I views of the glottis after failed direct laryngoscopy.

Given these findings we recommend use of the Airtraq, Bonfils, CTrach, GlideScope, McGrath, and Pentax AWS, used by an operator with reasonable prior experience, as an alternative intubation device following failed direct laryngoscopy (grade D recommendation) based on the SIGN criteria \[[@B12]\]. There may be extra reason to consider use of the Bonfils or Pentax AWS given their high 1st attempt success in this setting (grade D recommendation).

The limitations of the current review
-------------------------------------

### Classification using the Mallampati as the sole predictor of difficulty during direct laryngoscopy

The use of the Mallampati classification as the predictor of difficulty at direct laryngoscopy is an oversimplification. We have presented Shiga's work demonstrating that it is a very poor predictor of difficulty alone even when combined with other preoperative airway assessments. Unfortunately, the various predictors of difficulty at DL are variably presented in the literature, with Mallampati being the only consistently performed preoperative test. Studies examining patients with cervical spine limitation and obesity were included into the "at higher risk of difficulty group" as the authors and publishers considered these subjects to be at higher risk of difficulty.

### Grading the view at laryngoscopy

It is clear the ability of a laryngoscopic device to produce a good view of the glottis is a desirable characteristic of such a device. To allow some comparison between devices we considered a Cormack and Lehane grade I view of the glottis to be beneficial irrespective of whether it is obtained by direct or indirect means. This measure allows comparison between studies as a Cormack and Lehane grade I view is reliably recorded irrespective of whether the standard Cormack and Lehane, the various forms of modified Cormack and Lehane, or the Percentage of Glottic Opening is used in its assessment. Unfortunately the other grades of laryngoscopic view (grade 2, 2a, 2b etc.) are so variably recorded as to make other comparisons impossible. The limitation of using such a strict measure of glottic view improvement is the risk missing a lesser, but perhaps clinically significant improvement in glottic view afforded by device use, for instance an improvement from a grade 3 to a 2a view of the glottis.

The concept of using the Cormack and Lehane classification when comparing direct laryngoscopy with the variety of methods of videolaryngoscopy is questionable. These grading schemes are designed and validated for direct laryngoscopy only; however, this measure is used throughout all of the studies, as no other alternate scheme exists. The actual difficulty in tube passage during videolaryngoscopy (unlike direct laryngoscopy) is often independent of the view obtained on the screen. Therefore, the description of the view found during videolaryngoscopy as a simple Cormack and Lehane view analogous to that found during direct laryngoscopy may be inappropriate as it doesn't necessarily correlate with success. We suggest that during videolaryngoscopy a grading scheme that incorporates the difficulty encountered during passage of the endotracheal tube should be used. One simple method of grading this would be to describe the difficulty (easy, difficult, or failed) with a record of the glottic view obtained (modified Cormack and Lehane) followed by the name of the device. Difficulty could be defined by the performance of multiple attempts or the use of airway adjuncts to place the tube. For example, if the procedure is difficult but ultimately successful then this could be reported as a "Difficult Grade II GlideScope; rescued with the use of a tracheal tube introducer". This information would allow decisions to be made if the use of a videolaryngoscope is contemplated at a later date, but also allow the different types of videolaryngoscopes to be more easily compared.

### Device variability and the comparison of efficacy

These devices are "moving targets", i.e. new designs are continually introduced and existing designs are modified. This makes studies of older designs sometimes of questionable applicability to those currently being sold. We considered the devices in the current review to not have changed in form or function to an appreciable amount in the study period. Where new videolaryngoscope blade shapes were introduced, but failed to fulfill the inclusion criteria, they were excluded from the analysis (example the CMAC "D blade" and King Vision™). The differences between the devices extend toward other design features, such as the presence of a heating element to prevent fogging of the view etc. These differences cannot be easily described in a simple classification scheme.

### Operator performance and competency

Experience level and competency of the operators performing laryngoscopy was not presented or accounted for during analysis in any of the studies in the review. Instead the studies generally stated that the operators were appropriately trained and experienced in the procedure. Indeed, a simple expression of an operator's number years in practice or number of previous successful intubations doesn't provide a measure of the competency of a that operator in the use of a particular device. This is a serious limitation of the studies included in this review, which limits our conclusions and applicability of our recommendations. The current review was limited to device performance in appropriately experienced users. An improvement in the success of novices with the use of these devices was beyond the scope of this review. Any recommendations for their use must be considered in this context, and in the decision-making associated with a well-considered airway management strategy.

### Risk of bias within studies

When assessing the quality of randomized controlled trials particular emphasis is placed on the quality of the randomization process and blinding of subject and observer. Of these 2 factors, blinding is especially hard to address in a study design investigating videolaryngoscopy, and is generally poorly performed in the literature resulting in a universally poor score with respect to blinding. We found no article to which we could award the 1++ level of evidence class (excellent prospective). Randomized controlled trials may not be the best method of assessing the management of rare outcomes (such as true difficult laryngoscopy or intubation) or where blinding of operator to the device under study is impossible.

### Risk of bias across studies

Current methods to assess the quality of available evidence, outlined by the Agency for Healthcare Research and Quality (AHRQ) \[[@B100]\], are generally characterized as weighting their quality measures heavily towards randomized controlled trials. Relatively few of the methods suggested by the AHRQ actually allow observational retrospective studies to be included in any level of evidence summary. It is perhaps here where retrospective review of high quality outcome data in large databases generated by perioperative Anesthesia Information Management Systems (AIMS) can be particularly useful. Like many topics this subject likely suffers from publication bias and selective reporting within studies.

Conclusion
==========

In conclusion, we describe a field of research limited by poor subject classification and variable outcomes. We used a reasoned scientific approach to clarify and quantify the strength of evidence to support the use of some modern videolaryngoscopic devices. We found overall limited evidence of efficacy for many of the videolaryngoscopic devices. However, our review allowed us to produce the following limited recommendations: Firstly, in patients assessed to be at higher risk of difficult laryngoscopy we recommend the use of the Airtraq, CTrach, GlideScope, Pentax AWS, and V-MAC to achieve successful intubation (Grade A recommendation \[[@B12]\]). Secondly, in difficult direct laryngoscopy (Cormack and Lehane view III or IV on direct laryngoscopy) we cautiously recommend the use of the Airtraq, Bonfils, Bullard, CTrach, GlideScope and Pentax AWS to achieve successful intubation (Grade D recommendation \[[@B12]\]) used in accordance with the ASA practice guidelines for management of the Difficult Airway. Thirdly, additional evidence exists to recommend the use of the Airtraq, Bonfils, Bullard, CTrach, Glidescope, McGrath, and Pentax AWS following failed direct laryngoscopy to achieve successful intubation (Grade D recommendation \[[@B12]\]). Additional consideration should be made to use of the Bonfils and Pentax AWS given the evidence for 1st attempt success in this setting (Grade D recommendation). Future investigation would benefit from the precise qualification of study group airway characteristics, the use of consecutive rather than unselected subjects, the measurement and standardization of operator competency, the blinding of observers, and the standardization of outcome measures. These steps would reduce bias and help interpretation and metanalysis.
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Implication statement
=====================

This systematic review of the efficacy of videolaryngoscopy in orotracheal intubation classifies the patient groups under study into four clinical entities: unselected, at higher risk of difficulty, difficult direct laryngoscopy, and failed direct laryngoscopy. The evidence of efficacy is presented and recommendations are made.
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